Literature DB >> 32049032

Allosteric Activation of PI3Kα Results in Dynamic Access to Catalytically Competent Conformations.

Mayukh Chakrabarti1, Sandra B Gabelli2, L Mario Amzel3.   

Abstract

Class I phosphoinositide-3-kinases (PI3Ks) phosphorylate PIP2 at its 3' inositol position to generate PIP3, a second messenger that influences signaling cascades regulating cellular growth, survival, and proliferation. Previous studies have suggested that PI3Kα activation involves dislodging the p85α nSH2 domain from the p110α catalytic subunit by binding activated receptor tyrosine kinases. We carried out molecular dynamics simulations to determine, mechanistically and structurally, how PI3Kα conformations are influenced by physiological effectors and the nSH2 domain. We demonstrate that changes in protein dynamics mediated by allosteric regulation significantly increase the population of catalytically competent states without changing the enzyme ground-state structure. Furthermore, we demonstrate that modulation of active-site residue interactions with enzyme substrates can reciprocally influence nSH2 domain dynamics. Together, these results suggest that dynamic allostery plays a role in populating the catalytically competent conformation of PI3Kα, and provide a key platform for the design of novel chemotherapeutic PI3Kα inhibitors.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  catalytic mechanism; dynamic allostery; enzyme activation; molecular dynamics; phosphoinositide (3,4,5)-trisphosphate; phosphoinositide (4,5)-bisphosphate; phosphoinositide kinase; population increase; signaling pathway

Mesh:

Substances:

Year:  2020        PMID: 32049032      PMCID: PMC8057532          DOI: 10.1016/j.str.2020.01.010

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  45 in total

1.  Structure-based model of allostery predicts coupling between distant sites.

Authors:  Patrick Weinkam; Jaume Pons; Andrej Sali
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-08       Impact factor: 11.205

2.  Hinge-Shift Mechanism Modulates Allosteric Regulations in Human Pin1.

Authors:  Paul Campitelli; Jingjing Guo; Huan-Xiang Zhou; S Banu Ozkan
Journal:  J Phys Chem B       Date:  2018-02-07       Impact factor: 2.991

3.  Allostery without conformational change. A plausible model.

Authors:  A Cooper; D T Dryden
Journal:  Eur Biophys J       Date:  1984       Impact factor: 1.733

4.  CHARMM36m: an improved force field for folded and intrinsically disordered proteins.

Authors:  Jing Huang; Sarah Rauscher; Grzegorz Nawrocki; Ting Ran; Michael Feig; Bert L de Groot; Helmut Grubmüller; Alexander D MacKerell
Journal:  Nat Methods       Date:  2016-11-07       Impact factor: 28.547

5.  CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields.

Authors:  K Vanommeslaeghe; E Hatcher; C Acharya; S Kundu; S Zhong; J Shim; E Darian; O Guvench; P Lopes; I Vorobyov; A D Mackerell
Journal:  J Comput Chem       Date:  2010-03       Impact factor: 3.376

Review 6.  Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alpha.

Authors:  Chuan-Hsiang Huang; Diana Mandelker; Sandra B Gabelli; L Mario Amzel
Journal:  Cell Cycle       Date:  2008-02-27       Impact factor: 4.534

7.  Molecular Dynamics Simulations and Structural Network Analysis of c-Abl and c-Src Kinase Core Proteins: Capturing Allosteric Mechanisms and Communication Pathways from Residue Centrality.

Authors:  Amanda Tse; Gennady M Verkhivker
Journal:  J Chem Inf Model       Date:  2015-08-12       Impact factor: 4.956

8.  Structural insights into phosphoinositide 3-kinase catalysis and signalling.

Authors:  E H Walker; O Perisic; C Ried; L Stephens; R L Williams
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

9.  Structural basis of nSH2 regulation and lipid binding in PI3Kα.

Authors:  Michelle S Miller; Oleg Schmidt-Kittler; David M Bolduc; Evan T Brower; Daniele Chaves-Moreira; Marc Allaire; Kenneth W Kinzler; Ian G Jennings; Philip E Thompson; Philip A Cole; L Mario Amzel; Bert Vogelstein; Sandra B Gabelli
Journal:  Oncotarget       Date:  2014-07-30

10.  Insights into the mechanism of the PIK3CA E545K activating mutation using MD simulations.

Authors:  Hari Leontiadou; Ioannis Galdadas; Christina Athanasiou; Zoe Cournia
Journal:  Sci Rep       Date:  2018-10-19       Impact factor: 4.379

View more
  4 in total

1.  Drugging multiple same-allele driver mutations in cancer.

Authors:  Ruth Nussinov; Mingzhen Zhang; Ryan Maloney; Hyunbum Jang
Journal:  Expert Opin Drug Discov       Date:  2021-03-26       Impact factor: 7.050

Review 2.  Phosphorylation and Driver Mutations in PI3Kα and PTEN Autoinhibition.

Authors:  Ruth Nussinov; Mingzhen Zhang; Chung-Jung Tsai; Hyunbum Jang
Journal:  Mol Cancer Res       Date:  2020-12-07       Impact factor: 6.333

3.  Nanobodies and chemical cross-links advance the structural and functional analysis of PI3Kα.

Authors:  Jonathan R Hart; Xiao Liu; Chen Pan; Anyi Liang; Lynn Ueno; Yingna Xu; Alexandra Quezada; Xinyu Zou; Su Yang; Qingtong Zhou; Steve Schoonooghe; Gholamreza Hassanzadeh-Ghassabeh; Tian Xia; Wenqing Shui; Dehua Yang; Peter K Vogt; Ming-Wei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-12       Impact factor: 12.779

Review 4.  Mechanism of activation and the rewired network: New drug design concepts.

Authors:  Ruth Nussinov; Mingzhen Zhang; Ryan Maloney; Chung-Jung Tsai; Bengi Ruken Yavuz; Nurcan Tuncbag; Hyunbum Jang
Journal:  Med Res Rev       Date:  2021-10-25       Impact factor: 12.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.